John T. Cunningham

John T. Cunningham

Auto-generated profile, based on publicly available information

John T. Cunningham

Department of Cancer Biology, University of Cincinnati College of Medicine; Cincinnati, OH 45267, USA

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2007 in Nature
Verified
Journal Article
Closed access
PDF file
JCJohn T. Cunningham
John T. Cunningham
JRJoseph T. Rodgers
Joseph T. Rodgers
DADaniel H. Arlow
Daniel H. Arlow
FVFrancisca Vazquez
Francisca Vazquez
VMVamsi K. Mootha
Vamsi K. Mootha
PPPere Puigserver
Pere Puigserver

12 November 2012 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
LHLori S. Hart
Lori S. Hart
JCJohn T. Cunningham
John T. Cunningham
TDTatini Datta
Tatini Datta
SDSouvik Dey
Souvik Dey
FTFeven Tameire
Feven Tameire
CKConstantinos Koumenis
Constantinos Koumenis
The proto-oncogene c-Myc paradoxically activates both proliferation and apoptosis. In the pathogenic state, c-Myc–induced apoptosis is bypassed via a critical, yet poorly understood escape mechanism that promotes cellular transformation and tumorigenesis. The accumulation of unfolded proteins in the ER initiates a cellular stress program termed the unfolded protein response (UPR) to support cell survival. Analysis of spontaneous mouse and human lymphomas demonstrated significantly higher levels of UPR activation compared with normal tissues. Using multiple genetic models, we demonstrated that c-Myc and N-Myc activated the PERK/eIF2α/ATF4 arm of the UPR, leading to increased cell survival via the induction of cytoprotective autophagy. Inhibition of PERK significantly reduced Myc-induced autophagy, colony formation, and tumor formation. Moreover, pharmacologic or genetic inhibition of autophagy resulted in increased Myc-dependent apoptosis. Mechanistically, we demonstrated an important link between Myc-dependent increases in protein synthesis and UPR activation. Specifically, by employing a mouse minute (L24+/–) mutant, which resulted in wild-type levels of protein synthesis and attenuation of Myc-induced lymphomagenesis, we showed that Myc-induced UPR activation was reversed. Our findings establish a role for UPR as an enhancer of c-Myc–induced transformation and suggest that UPR inhibition may be particularly effective against malignancies characterized by c-Myc overexpression.

14 January 2019 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
YXYichen Xu
Yichen Xu
MPMauro Poggio
Mauro Poggio
HJHyun Yong Jin
Hyun Yong Jin
ZSZhen Shi
Zhen Shi
CFCraig M. Forester
Craig M. Forester
DRDavide Ruggero
Davide Ruggero

1 May 2014 in Cell
Verified
Journal Article
Closed access
JCJohn T. Cunningham
John T. Cunningham
MMMelissa V. Moreno
Melissa V. Moreno
ALAlessia Lodi
Alessia Lodi
SRSabrina M. Ronen
Sabrina M. Ronen
DRDavide Ruggero
Davide Ruggero

2 May 2018 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
HNHao G Nguyen
Hao G Nguyen
CCCrystal S. Conn
Crystal S. Conn
YKYae Kye
Yae Kye
LXLingru Xue
Lingru Xue
CFCraig M. Forester
Craig M. Forester
DRDavide Ruggero
Davide Ruggero
The PERK-eIF2α pathway is activated in aggressive prostate cancer and associated with patient outcome, providing a therapeutic target for the disease.

1 April 2012 in Cell Metabolism
Verified
Journal Article
Closed access
SBSharon M. Blättler
Sharon M. Blättler
JCJohn T. Cunningham
John T. Cunningham
FVFrancisco Verdeguer
Francisco Verdeguer
HCHelen Chim
Helen Chim
WHWilhelm Haas
Wilhelm Haas
PPPere Puigserver
Pere Puigserver